ArticleCureus2025
A Single-Center Retrospective Study on Noninvasive Prediction of Terson Syndrome in Aneurysmal Subarachnoid Hemorrhage (aSAH) Patients: The Role of CT-Measured Posterior Globe Thickness and Age.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Terson syndrome (TS), an intraocular hemorrhage secondary to aneurysmal subarachnoid hemorrhage (aSAH), has a high incidence rate. Clinically, patients with aSAH often present with concomitant TS; however, owing to the difficulty in performing ophthalmic examinations in critically ill patients, many cases may be missed. This study aimed to develop and evaluate a CT-based diagnostic model incorporating posterior globe thickness to predict TS in patients with aSAH. Materials and methods This was a retrospective study on patients who underwent direct surgery or endovascular treatment for ruptured cerebral aneurysms at our institution between January 1, 2018, and August 31, 2025 (analyzed by eye). We extracted data from eyes definitively diagnosed with TS via ophthalmic examination. In addition to collecting epidemiological and clinical data, posterior globe thickness was measured for each eye. Statistical analyses included the Mann-Whitney U test, chi-square test, generalized estimating equation (GEE) logistic regression analysis, and receiver operating characteristic (ROC) analysis. Statistical significance was set at p < 0.05. Results A total of 177 patients (354 eyes) received aSAH treatment, of whom 26 individuals (52 eyes) underwent ophthalmic examination, and within this subgroup, 11 patients (17 eyes) were diagnosed with TS. In the univariate GEE logistic regression analysis, the presence of TS was significantly correlated with age (p=0.005), World Federation of Neurosurgical Societies (WFNS) grade (p=0.021), complaints of visual and visual field impairment (p=0.021), and posterior globe thickness (p=0.038). The multivariate GEE logistic regression analysis demonstrated that age and posterior globe thickness significantly influenced the risk of developing TS. In this final multivariate model, the odds of having TS decreased by a factor of 0.85 for every one-year increase in age (p=0.007), whereas the odds increased by a factor of 13.74 for every 1 mm increase in posterior globe thickness (p=0.027). ROC analysis, performed using this final multivariate model, yielded a calculation to determine the age-dependent cutoff for posterior globe thickness: Cutoff(mm)≈-1.295+0.0637×Age (years), which showed a sensitivity and specificity of 82.4% and 82.9%, respectively. Conclusion This study proposes a noninvasive prediction model for estimating TS based on CT measurements of posterior globe thickness. Serving as a practical triage tool, these findings suggest that incorporating age significantly enhances the diagnostic utility. To ensure broad generalizability and facilitate its application in clinical practice, prospective multicenter trials are necessary to validate these results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.